Adaptimmune Therapeutics PLC
NASDAQ:ADAP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Adaptimmune Therapeutics PLC
NASDAQ:ADAP
|
UK |
|
Blackbird Critical Metals Corp
OTC:BBCMD
|
CA |
|
TTEC Holdings Inc
NASDAQ:TTEC
|
US |
|
Henry Schein Inc
NASDAQ:HSIC
|
US |
|
Ascent Industries Co
NASDAQ:ACNT
|
US |
|
Enseval Putera Megatrading Tbk PT
IDX:EPMT
|
ID |
|
K
|
Kancera AB
F:3EE0
|
SE |
|
C
|
CleanTech Lithium plc
LSE:CTL
|
JE |
|
S
|
Sanford Ltd
OTC:SARDY
|
NZ |
Shareholder Yield
Current shareholder yield for ADAP is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
ADAP Price
Adaptimmune Therapeutics PLC
| Average Annual Return | -47.28% |
| Standard Deviation of Annual Returns | 17.11% |
| Max Drawdown | -99% |
| Market Capitalization | 580k USD |
| Shares Outstanding | 16 111 111 |
| Percentage of Shares Shorted | 14.34% |
